InsiderTrades

Form 4 for XYL Xylem Inc.

Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-09 · accession 0001209191-21-063864 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-10 2021-11-09 XYL Decker Patrick Pres, CEO, Dir M - OptEx $36.81 +54.6K 292.5K +23% +$2.01M
D 2021-11-10 2021-11-09 XYL Decker Patrick Pres, CEO, Dir S - Sale+OE $132.91 -54.6K 237.9K -19% -$7.26M
D 2021-11-10 2021-11-09 XYL Decker Patrick Pres, CEO, Dir M - OptEx $0.00 -54.6K 56.3K -49% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-09 M A 54,643 $36.81 292,532 D — —
2 Common Common Stock 2021-11-09 S D 54,643 $132.91 237,889 D — — (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on June 8, 2021. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 26,858 Shares were executed at a range of prices from $131.93 to $132.92. 27,785 Shares were executed at a range of prices from 132.93 to $133.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
3 Derivative Stock Option (Right to Buy) 2021-11-09 M D 54,643 $0.00 56,298 D $36.81 · — to 2024-02-25 54,643 Common (F3) These options are fully vested and exercisable.